Abstract
Get full access to this article
View all access options for this article.
References
1.
Boelaert
K
. 2010 . Treatment of Graves' disease with antithyroid drugs: current perspectives . Thyroid , 20 :943 –946 .
2.
Chattaway
JM
,
Klepser
TB
. 2007 . Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy . Ann Pharmacother , 41 :1018 –1022 .
3.
Mortimer
RH
,
Cannell
GR
,
Addison
RS
,
Johnson
LP
,
Roberts
MS
,
Bernus
I
. 1997 . Methimazole and propylthiouracil equally cross the perfused human term placenta . J Clin Endocrinol Metab , 82 :3099 –3102 .
4.
Cooper
DS
,
Rivkees
SA
. 2009 . Putting propylthiouracil into perspective . J Clin Endocrinol Metab , 94 :1881 –1882 .
5.
Abalovich
AM
,
Amino
N
,
Barbour
IA
,
Cobin
RH
,
De groot
LJ
,
Glinoer
D
,
Mandel
SJ
,
Stagnaro-Green
A
. 2007 . Management of thyroid dysfunction during pregnancy and post partum: an Endocrine Society Clinical Practice Guideline . J Clin Endocrinol Metab , 9 ,8 Suppl :S1 –S47 .
6.
Clementi
M
,
di Gianantonio
E
,
Cassina
M
,
Leoncini
L
,
Botto
LD
,
Mastroiacovo
P
. the SAFE_Med Study Group . 2010 . Treatment of hyperthyroidism in pregnancy and birth defects . J Clin Endocrinol Metab , 95 :E337 –E341 .